Samsung Pharmaceutical Ind Co Ltd (001360.KS)
001360.KS on Korea Stock Exchange
2,265.00KRW
2 Aug 2013
2,265.00KRW
2 Aug 2013
Price Change (% chg)
₩55.00 (+2.49%)
₩55.00 (+2.49%)
Prev Close
₩2,210.00
₩2,210.00
Open
₩2,235.00
₩2,235.00
Day's High
₩2,355.00
₩2,355.00
Day's Low
₩2,235.00
₩2,235.00
Volume
90,650
90,650
Avg. Vol
112,100
112,100
52-wk High
₩3,990.00
₩3,990.00
52-wk Low
₩1,905.00
₩1,905.00
About
SAMSUNG PHARM. IND. Co., LTD. is a Korea-based company engaged in the manufacturing of pharmaceutical products. The Company provides over the counter (OTC) pharmaceuticals, prescription pharmaceuticals, healthcare food, healthcare drinks, insecticides and others. The pharmaceutical products consist of gastrointestinal drugs,... (more)
No analyst recommendations are available for 001360.KS.
Overall
| Beta: | 0.60 |
| Market Cap (Mil.): | ₩25,434.99 |
| Shares Outstanding (Mil.): | 11.51 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| 001360.KS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -581.08 | -- | -- |
| ROI: | -5.25 | 19.48 | 18.76 |
| ROE: | -8.17 | 20.17 | 19.59 |
Earnings vs.
Estimates
No consensus analysis data available.
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$483.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

